Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.

Molecular medicine (Cambridge, Mass.)

Volumn 17, Issue 9-10, 2011, Pages 917-924

  Eghtesad, Saman ^a   Jhunjhunwala, Siddharth ^b   Little, Steven R ^b   Clemens, Paula R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MTOR PROTEIN, MOUSE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DIAPHRAGM; DISEASE MODEL; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVATION; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; SKELETAL MUSCLE; TIME; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIAPHRAGM; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; PHOSPHORYLATION; SIROLIMUS; TIME FACTORS; TOR SERINE-THREONINE KINASES;

MLCS; MLOWN;

EID: 84858780524     PISSN: None     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2010.00256     Document Type: Article

References (0)